(Date:11/23/2009)...able in German . , Of all global carbon dio...tmosphere where it contributes to global warming. ...rial ecosystems such as forests, grasslands and pe...ic and terrestrial ecosystems is considered one of...climate change. However, new greenhouse gas bookke...
(Date:11/22/2009)...ene deletion can increase the likelihood of immune...on, an international team of researchers reports i...Genetics . When the gene, called UGT2B17, is missi...pient,s, transplants have a significantly greater ...s-host disease, in which immune cells from the don...
(Date:11/21/2009)...vember 20,2009 / b3c newswire / - KINAXO Biotech...cing round, gaining two new investors in the compa...NAXO reports that Jrgen Schumacher has been electe..., KINAXO shareholders Axel Ullrich, Hellmut Kirc...tutional investors Mountain Partners, BioM, High-T...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 1Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 2Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 3Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 1Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 2Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 3(Date:11/19/2009)...e able to charge their cell phones and other perso...t discovery made by UC San Diego engineers could l...could do just this. , In recent research, publi...ru, a professor in the UCSD Department of Mechanic...student Mark Hoefer, have found that artificially ...
(Date:11/19/2009)...Newswire-FirstCall/ -- Omeros Corporation (Nasdaq:...ts for the third quarter ended September 30, 2009....eros reported a net loss of $3.9 million, or $1.34...ion, or $2.54 per share, for the same period in 20...the Company reported a net loss of $15.5 million, ...
(Date:11/19/2009)..., Md., Nov. 19 Spherix I...echnology for diabetes therapy, and a provider of ...od, supplement, biotechnology and pharmaceutical c... reported $6.3 million registered direct placement... its common stock and warrants to purchase up to 1...
(Date:11/19/2009)...19 Spherix Incorporated ...r diabetes therapy, and a provider of technical an...nt, biotechnology and pharmaceutical companies, to...ing of Shareholders. ,, At the meeting, shareho...cted the following members to the Board of Directo...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4...ights from the American Chemical Society journal, ...ert!, the online science news service for reporter... In the current issue we learn about a new techniq...report on a small molecule that binds to a specifi...
...abortion is made legal, safe and easily accessible...e fourth paper in the Online/Series published toda...rtions are done by individuals without prerequisit... standards, or both. Almost all unsafe abortions -...
...rchers at the Animal Health Research Centre (CReSA...ainst diseases produced by prion, such as Bovine S...ublished in the Journal of Virology, show that imp...vaccines on animal models, enabling a significant ...
...gy and conservation experts from the University of...rk together to protect threatened Caribbean sea tu...rseas Territory, once supported one of the world's...e 6.5 million adult green and loggerhead turtles. ...
The CReSA is working on a new strategy to combat spongiforms 2Governments should act now to save threatened turtles 2...ientists have discovered a novel role for the toxi...deadly infection linked to the use of highly absor...toxic shock toxin, produced by the notorious bacte...er switch that blocks the infecting bacterium's pr...
... Researchers nationwide have halted the part of a ...the risks versus the benefits of healthy postmenop...stin.......That's because after five years of data...tweighed the benefits, scientists said. Taking the...
...ale research with other sciences and technologies ...rformance, scientists say in a report released tod...uman Performance." The report, issued by the Nati...mmerce, examines the integrated role of nanotechno...
...on, U.K. and Kenilworth, N.J., July 10, 2002 In a...urnal Nature, researchers at Genome Therapeutics (...ing-Plough Corporation (NYSE: SGP) describe the id...ked to asthma. A complex disorder with both envir...
Surprising role for Staphs toxic shock toxin 2Surprising role for Staphs toxic shock toxin 3National study halted since health risks exceed benefits in postmenopausal women on estrogen 2National study halted since health risks exceed benefits in postmenopausal women on estrogen 3Genome Therapeutics, University of Southampton and Schering-Plough identify novel asthma gene 2Genome Therapeutics, University of Southampton and Schering-Plough identify novel asthma gene 3